J Cardiovasc Transl Res
-
Publication Venue For
- Greater Pain Severity Is Associated with Worse Outcomes in Patients with Heart Failure. 2021
- Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.. 14:120-124. 2021
- Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.. 13:894-899. 2020
- A Contemporary Picture of Congestion in Heart Failure: from Dropsy Impression to Multifaceted Reality.. 13:507-508. 2020
- A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).. 13:540-548. 2020
- Addressing Orthostatic Hypotension in Heart Failure: Pathophysiology, Clinical Implications and Perspectives.. 13:549-569. 2020
- Correlation of Quantitated Intravascular Volume with Blood Pressure in Patients with Systemic Hypertension.. 13:528-530. 2020
- Increasing Blood Pressure by Greater Splanchnic Nerve Stimulation: a Feasibility Study.. 13:509-518. 2020
- Effect of Androgen Deprivation Therapy on Metabolic Complications and Cardiovascular Risk.. 13:451-462. 2020
- Heterogeneous Outcomes of Heart Failure with Better Ejection Fraction.. 13:142-150. 2020
- Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.. 9:374-399. 2016
- Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.. 9:102-118. 2016
- Linking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions.. 8:506-527. 2015
- William Campbell Little, M.D. In Memoriam.. 8:569. 2015
- A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience.. 8:449-457. 2015
- Why Is Infarct Expansion Such an Elusive Therapeutic Target?. 8:421-430. 2015
- Gene Expression Signatures and the Spectrum of Coronary Artery Disease.. 8:339-352. 2015
- Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2.. 8:293-318. 2015
- Mechanotransduction mechanisms for intraventricular diastolic vortex forces and myocardial deformations: part 1.. 8:76-87. 2015
- Vortex formation time is not an index of ventricular function.. 8:54-58. 2015
- Biological and analytical stability of a peripheral blood gene expression score for obstructive coronary artery disease in the PREDICT and COMPASS studies.. 7:615-622. 2014
- Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise.. 7:347-361. 2014
- Lessons learned from negative clinical trials evaluating antithrombotic therapy for ischemic heart disease.. 7:112-125. 2014
- Evaluation of right and left ventricular diastolic filling.. 6:623-639. 2013
- Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial.. 5:366-374. 2012
- Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.. 5:92-99. 2012
- An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.. 4:674-682. 2011
- Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.. 3:704-716. 2010
- Intracardiac echocardiography in congenital heart disease.. 2:19-23. 2009
- Clinical genomic testing: getting it right.. 1:17-20. 2008